Platforms for synthesis and testing of emerging and zoonotic viruses
新兴病毒和人畜共患病毒的合成和测试平台
基本信息
- 批准号:8375872
- 负责人:
- 金额:$ 54.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-03-01 至 2014-02-28
- 项目状态:已结题
- 来源:
- 关键词:AnimalsAttenuatedBioinformaticsBiological ModelsBioterrorismCategoriesChiropteraClinicalComputer SimulationCoronavirusCultured CellsDatabasesDeletion MutationDevelopmentDistantEngineeringEpidemicEpithelial CellsFerretsFrequenciesFutureGenetic TranscriptionGenomeGoalsGrowthHumanHuman VirusIn VitroInterferonsInterventionKineticsMapsMissionModelingMolecular BiologyMovementMusMutationOrganismPathogenesisPharmaceutical PreparationsPhenotypePhylogenetic AnalysisPolyproteinsProteinsPublic HealthRecombinantsRecoveryRoleSARS coronavirusSourceSubgroupSystemTestingTransgenic MiceVaccinesVariantViralVirulenceVirusVirus ReceptorsViverridaeagedattenuationbiodefensecoronavirus spike glycoproteindesignengineering designhuman coronavirushuman diseasein vivomouse modelnovel viruspandemic diseasepathogenpreventprogramsreceptorrecombinational repairreconstructionreplicaseresponsesenescencestructural biologysynthetic biologytooltransmission process
项目摘要
There has been an increase in recognized trans-species movement and human disease from zoonotic
viruses, as well as increased concern about intentional design and introduction of zoonotic organisms in
bioterrorism. Our ability to respond to such emerging zoonotic-human viruses has been limited by our
inability to predict the source, frequency, and mechanisms of virus host-species switching and adaptation.
Recent advances in bioinformatics, molecular biology, structural biology, and synthetic biology, provide tools
to design, synthetically reconstruct, and test new and emerging pathogens from sequence databases alone.
However, development of broadly-applicable platforms strategies for emerging viruses has not occurred, in
part due to concerns about possible misuse of synthetic biology and engineered host-range variants. We
propose that is an essential mission of the RCEs to demonstrate the safe use and potential of synthetic
biology in rapid response platforms. SARS-coronavirus (SARS-CoV) is a category C emerging pathogen that
caused severe human disease worldwide. SARS-CoV is proposed to have emerged in humans following
trans-species movement of Bat-Coronaviruses (Bat-CoV) that have been identified by sequence but have
not been grown in culture. This proposal uses SARS-CoV and zoonotic Bat-CoV to establish platforms for
recovery and testing of zoonotic viruses. The proposed program is comprised of four integrated Specific
Aims that will design and synthetically reconstruct distinct serogroups of zoonotic bat-CoV from sequence
databases, and define the determinants of host-species movement and adaptation in culture, and in young
and senescent mouse models. Further, the Aims will develop strategies for stable and universal attenuation
of pathogenesis of all coronavirus groups. The established approaches will allow rapid response and control
of natural and deliberately designed human coronaviruses, and also will be directly applicable to
development of similar specific rapid-response systems for recovery, analysis, attenuation and response to
other category A, B, or C emerging pathogens of concern for human disease or bioterrorism.
公认的跨物种移动和人畜共患病的人类疾病有所增加
病毒,以及对故意设计和引入人畜共患生物体的日益关注
生物恐怖主义。我们应对此类新出现的人畜共患病毒的能力受到我们的限制。
无法预测病毒宿主物种转换和适应的来源、频率和机制。
生物信息学、分子生物学、结构生物学和合成生物学的最新进展提供了工具
仅从序列数据库中设计、综合重建和测试新的和正在出现的病原体。
然而,针对新兴病毒的广泛适用的平台策略尚未开发出来。
部分原因是担心合成生物学和工程宿主范围变异可能被滥用。我们
提出 RCE 的一项基本任务是展示合成药物的安全使用和潜力
快速反应平台中的生物学。 SARS 冠状病毒 (SARS-CoV) 是一种 C 类新发病原体,
在全世界范围内引起了严重的人类疾病。 SARS-CoV 被认为是在人类中出现的
蝙蝠冠状病毒(Bat-CoV)的跨物种移动已通过序列鉴定,但
没有在文化中成长。该提案利用 SARS-CoV 和人畜共患蝙蝠-CoV 建立平台
人畜共患病病毒的回收和测试。拟议的计划由四个综合具体
目标是根据序列设计和综合重建人畜共患蝙蝠冠状病毒的不同血清群
数据库,并定义文化和年轻人中宿主物种运动和适应的决定因素
和衰老小鼠模型。此外,目标将制定稳定且普遍的衰减策略
所有冠状病毒群的发病机制。既定方法将允许快速响应和控制
天然和精心设计的人类冠状病毒,也将直接适用于
开发类似的特定快速响应系统,用于恢复、分析、衰减和响应
其他 A、B 或 C 类新出现的引起人类疾病或生物恐怖主义的病原体。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark R Denison其他文献
Mark R Denison的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark R Denison', 18)}}的其他基金
Inhibitors of Coronavirus Fidelity and Cap Methylation as Broadly Applicable
冠状病毒保真度和帽甲基化抑制剂广泛适用
- 批准号:
9217551 - 财政年份:2014
- 资助金额:
$ 54.55万 - 项目类别:
Platforms for synthesis and testing of emerging and zoonotic viruses
新兴病毒和人畜共患病毒的合成和测试平台
- 批准号:
8234184 - 财政年份:2011
- 资助金额:
$ 54.55万 - 项目类别:
相似国自然基金
II型螺旋神经元P2X3受体在长期低强度噪声暴露致耳蜗去掩蔽效应减弱中的作用机制研究
- 批准号:82301306
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
绵羊甘露聚糖结合凝集素(MBL)在MO人工感染中致病性减弱的作用机制研究
- 批准号:32360812
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
受HPV E6/E7调控的新lncRNA CRL通过减弱铁死亡抑制宫颈上皮内瘤变进展的机制研究
- 批准号:82301838
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
新冠病毒变异株毒力减弱的分子机制及规律研究
- 批准号:82372223
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
长白山阔叶红松林冻融期土壤N2O排放对高氮沉降减弱的响应研究
- 批准号:42301052
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Exploring Tr1-regulated transcription networks underpinning adaptation of pathogenic Anaplasma to the tick host
探索 Tr1 调节的转录网络支持致病性无形体对蜱宿主的适应
- 批准号:
10727435 - 财政年份:2023
- 资助金额:
$ 54.55万 - 项目类别:
Elucidating the Molecular Mechanisms and Cellular Specificity of HDAC Inhibitor Efficacy in Diastolic Dysfunction
阐明 HDAC 抑制剂治疗舒张功能障碍的分子机制和细胞特异性
- 批准号:
10664222 - 财政年份:2023
- 资助金额:
$ 54.55万 - 项目类别:
BCCMA: Translational research to improve the care of advanced bladder cancer
BCCMA:改善晚期膀胱癌护理的转化研究
- 批准号:
10588312 - 财政年份:2023
- 资助金额:
$ 54.55万 - 项目类别:
Neurodevelopmental role of a tRNA methyltransferase underlying intellectual disability
tRNA 甲基转移酶对智力障碍的神经发育作用
- 批准号:
10540878 - 财政年份:2022
- 资助金额:
$ 54.55万 - 项目类别:
Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis
早期体内表达的抗原及其在球孢子菌病毒力、免疫反应和疫苗中的作用
- 批准号:
10356628 - 财政年份:2022
- 资助金额:
$ 54.55万 - 项目类别: